Sign in

CIK 0001623526

  • Non-accelerated filer
  • Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471144582
Phone
+1 781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
  1. 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $11.37 ($113,653)
  2. 4 Open-market sale 10% owner sold 3,600,000 shares at $11.60 ($41,760,000)
  3. 4 Planned sale CHIEF MEDICAL OFFICER sold 9,426 shares at $13.23 ($124,684)
  4. 4 Planned sale COO & CBO sold 61,329 shares at an average $13.23 ($811,212)
  5. 4 Planned sale GENERAL COUNSEL & CORP SEC sold 5,126 shares at an average $13.20 ($67,668)
  6. 4 Open-market sale CFO sold 4,116 shares at $6.10 ($25,102)
  7. 4 Open-market sale CHIEF MEDICAL OFFICER sold 4,116 shares at $6.10 ($25,102)
  8. 4 Open-market sale COO & CBO sold 4,116 shares at $6.10 ($25,102)
  9. 4 Open-market sale CEO sold 11,150 shares at $6.10 ($67,999)
  10. 4 Open-market sale GENERAL COUNSEL & CORP SEC sold 2,349 shares at $6.10 ($14,326)
  11. 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $7.75 ($77,469)
  12. 4 Option exercise Director acquired 31,739 shares (option exercise)
  13. 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $4.80 ($47,991)
  14. 4 Planned sale Chief Medical Officer sold 10,000 shares at $5.74 ($57,352)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 16 · 305 filings